A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether drugs like Wegovy, Ozempic ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to find out why LLY stock is a Hold.

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing cancer ...

So researchers have been wondering: Might blockbuster weight-loss drugs like Wegovy, Ozempic and Zepbound also play ... data from 43 U.S. health systems to compare two groups: people with obesity ...

Paradromics, a brain-computer-interface startup, inserted its brain implant in a person—briefly—in an early test of its ...